R--National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH OLAO

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98027R00015

NAICS

541618 - Other Management Consulting Services

Classification Code

R410

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), is seeking information from qualified organizations regarding the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation Funnel Clinical Validation Core. This notice, issued as a Sources Sought under procurement identifier 75N98027R00015, is intended to identify potential contractors capable of supporting the clinical validation activities within the NIBIB Innovation Funnel. The primary purpose of this procurement is to establish a Clinical Validation Core that will facilitate the evaluation and validation of innovative biomedical imaging and bioengineering technologies. The scope encompasses management consulting services, as classified under NAICS code 541618 (Other Management Consulting Services), with a focus on supporting the clinical validation process for emerging technologies developed through the NIBIB Innovation Funnel. The expected outcomes include robust, evidence-based validation of new biomedical solutions, ensuring their readiness for clinical application and broader adoption. Key requirements for this opportunity include expertise in management consulting within the biomedical and bioengineering sectors, particularly as it relates to clinical validation processes. Contractors are expected to provide comprehensive support for the design, implementation, and assessment of clinical validation studies, working closely with NIBIB stakeholders to ensure that innovative technologies meet rigorous clinical standards. Deliverables may include strategic planning, project management, data analysis, and reporting services that contribute to the successful validation and potential commercialization of new biomedical innovations. The contracting entity is the NIH OLAO, a federal office within the Department of Health and Human Services. The primary point of contact for this notice is Melanie D. Suarez, who can be reached via email at [email protected]. Interested parties are encouraged to review the notice and any associated attachments on SAM.gov (Opportunity ID: 0e86fc6ca3ee4a43937c38ff84b556cc) for further details and to submit responses by April 12, 2026. This procurement is currently in the Sources Sought phase, meaning NIH is gathering information to inform future solicitation strategies. There are no set-aside requirements or special considerations specified at this stage. Contractors should note that the core elements of this opportunity—clinical validation support for biomedical innovations, management consulting expertise, and collaboration with NIH/NIBIB—will remain constant throughout the contract lifecycle. For contractors with relevant experience in biomedical management consulting and clinical validation, this opportunity represents a chance to contribute to the advancement of innovative healthcare technologies. Interested organizations should assess their capabilities against the stated requirements and consider responding to the notice to help shape the future solicitation.